TWiV 889: COVID-19 clinical update #110 with Dr. Daniel Griffin
In COVID-19 clinical update #110, Dr. Griffin covers hospital admissions during variant outbreaks, viral load in vaccinated and unvaccinated individuals, predictive capacity of symptoms in children, comparison of antigen tests, incidence of myocarditis after vaccination, steroids during replication phase, Paxlovid efficacy and safety, fluvoxamine, sabizabutin, colchicine, and prevalence of infection in Africa.
Subscribe (free):\xa0Apple Podcasts,\xa0Google Podcasts,\xa0RSS,\xa0email
Become a\xa0patron\xa0of\xa0TWiV!
Links for this episode- Hospital admissions\xa0during Omicron and Delta variant outbreaks (Lancet)
- Viral load\xa0in unvaccinated and vaccinated individuals (Nat Med)
- Predictive Capability\xa0of symptoms in children (Clin Inf Dis)
- Comparison of antigen tests\xa0(medRxiv)
- Incidence of Myocarditis\xa0after COVID19 and non-COVID19 vaccination (Lancet)
- Steroids\xa0during viral replication phase (Resp)
- Paxlovid\xa0efficacy and safety\xa0(Pfizer)
- Fluvoxamine & Outpatient Management\xa0(JAMA)
- Sabizabutin\xa0efficacy and safety\xa0(Veru)
- Colchicine\xa0and lack of benefit (Lancet)
- SARS-CoV-2\xa0prevalence in Africa\xa0(medRxiv)
- Contribute to ASTMH fundraiser at PWB
- Dr. Griffin\u2019s treatment guide (pdf)
- Letters read\xa0on TWiV 889 33:35
- Timestamps by Jolene. Thanks!
Intro music is by\xa0Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv